Yestar Healthcare Holdings Co Ltd (HK:2393)
:2393
Want to see HK:2393 full AI Analyst Report?
2393 Stock Chart & Stats
HK$0.10
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.10
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.07 - HK$0.20
Previous CloseN/A
Volume710.00K
Average Volume (3M)2.34M
Market Cap
HK$160.74M
Enterprise ValueHK$116.17M
Total Cash (Recent Filing)HK$234.51M
Total Debt (Recent Filing)HK$211.05M
Price to Earnings (P/E)―
Beta0.48
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding2,331,590,000
10 Day Avg. Volume1,184,000
30 Day Avg. Volume2,342,546
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)0.56
Price to Sales (P/S)0.14
P/FCF Ratio0.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved Balance SheetThe shift to positive equity and materially lower debt improves financial flexibility and reduces refinancing risk. Durable balance-sheet repair supports capacity for investment or downturns, making the company more resilient over the next several quarters.
Strong 2025 Cash GenerationMaterial operating and free cash flow in 2025 enhances internal funding for working capital, capex, and deleveraging without reliance on markets. Consistent cash conversion underpins medium-term stability and allows strategic flexibility even if earnings remain volatile.
Consumer-facing Medical Services PlatformA platform concentrating on medical aesthetics and eye care provides diversified, service-based revenue streams with repeat customer potential. Structural demand for clinical aesthetic and ophthalmic services supports long-term revenue opportunities and cross-selling across clinics.
Bears Say
Sharp Revenue ContractionA ~25% revenue decline in 2025 following flat/weak 2024 signals deteriorating demand or market share loss. Sustained top-line weakness undermines scale economics, stresses fixed-cost absorption, and constrains durable margin and earnings recovery prospects.
Unstable ProfitabilitySwinging net margins and a return to loss-making reduce earnings predictability and impair return on equity. Persistent profit volatility limits the company's ability to fund growth internally, resume distributions, or reliably sustain operating investments.
History Of Cash-flow VolatilityAlthough 2025 cash flow improved, prior years showed negative or weak cash generation. That cyclicality raises doubt about durability of cash returns through downturns and complicates long-term planning for capex, debt reduction, or strategic initiatives.
Yestar Healthcare Holdings Co Ltd News
2393 FAQ
What was Yestar Healthcare Holdings Co Ltd’s price range in the past 12 months?
Yestar Healthcare Holdings Co Ltd lowest stock price was HK$0.07 and its highest was HK$0.20 in the past 12 months.
What is Yestar Healthcare Holdings Co Ltd’s market cap?
Yestar Healthcare Holdings Co Ltd’s market cap is HK$160.74M.
When is Yestar Healthcare Holdings Co Ltd’s upcoming earnings report date?
Yestar Healthcare Holdings Co Ltd’s upcoming earnings report date is Aug 27, 2026 which is in 97 days.
How were Yestar Healthcare Holdings Co Ltd’s earnings last quarter?
Yestar Healthcare Holdings Co Ltd released its earnings results on Mar 27, 2026. The company reported -HK$0.038 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.038.
Is Yestar Healthcare Holdings Co Ltd overvalued?
According to Wall Street analysts Yestar Healthcare Holdings Co Ltd’s price is currently Overvalued.
Does Yestar Healthcare Holdings Co Ltd pay dividends?
Yestar Healthcare Holdings Co Ltd pays a Annually dividend of HK$0.055 which represents an annual dividend yield of N/A. See more information on Yestar Healthcare Holdings Co Ltd dividends here
What is Yestar Healthcare Holdings Co Ltd’s EPS estimate?
Yestar Healthcare Holdings Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yestar Healthcare Holdings Co Ltd have?
Yestar Healthcare Holdings Co Ltd has 2,331,590,000 shares outstanding.
What happened to Yestar Healthcare Holdings Co Ltd’s price movement after its last earnings report?
Yestar Healthcare Holdings Co Ltd reported an EPS of -HK$0.038 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.02%.
Which hedge fund is a major shareholder of Yestar Healthcare Holdings Co Ltd?
Currently, no hedge funds are holding shares in HK:2393
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Yestar Healthcare Holdings Co Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
44.31%
12-Months-Change
Fundamentals
Return on Equity
-17.70%
Trailing 12-Months
Asset Growth
-12.60%
Trailing 12-Months
Company Description
Yestar Healthcare Holdings Co Ltd
Yestar Healthcare Holdings Company Limited, an investment holding company, engages in the manufacture, distribution, and sale of medical imaging products in Mainland China. It operates through two segments, Imaging Printing Products, and Medical Products and Equipment. The Imaging Printing Products segment manufactures and sells Fujifilm color photographic paper, industrial NDT X-ray films, and PWB films; and trades in imaging equipment. Its products are used in professional and minilabs; and industrial imaging applications. This segment provides NDT X-ray films under the Yes!Star brand. The Medical Products and Equipment segment manufactures and sells medical dry and wet films, and dental films; and sells medical equipment and diagnostic reagents. The company also distributes in vitro diagnostic products. In addition, it engages in the biotechnology development activities; management of supply chain activities; and provision of freight transportation services. The company was formerly known as Yestar International Holdings Company Limited and changed its name to Yestar Healthcare Holdings Company Limited in January 2017. Yestar Healthcare Holdings Company Limited was founded in 1971 and is headquartered in Shanghai, the People's Republic of China.
Technical Analysis
Vincent Medical Holdings Limited
―
Sisram Medical Ltd.
―
China Isotope & Radiation Corp.
―
Suzhou Basecare Medical Corp. Ltd. Class H
―
Austar Lifesciences Ltd.
―